{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T08:49:07Z","timestamp":1791535747866,"version":"4.3.4"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,1]]},"DOI":"10.1093\/jnci\/djag191","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T11:49:56Z","timestamp":1781178596000},"page":"1788-1790","source":"Crossref","is-referenced-by-count":0,"title":["The unfinished story of pregnancy-associated breast cancer"],"prefix":"10.1093","volume":"118","author":[{"given":"Cyril","family":"Roussel-Simonin","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Gustave Roussy , Villjuif,","place":["France"]},{"name":"Drug Development Department (DITEP), Gustave Roussy , Villjuif,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7906-0991","authenticated-orcid":false,"given":"Elie","family":"Rassy","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Gustave Roussy , Villjuif,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,25]]},"reference":[{"key":"2026100903524777600_djag191-B1","doi-asserted-by":"publisher","first-page":"105553","DOI":"10.1016\/j.esmoop.2025.105553","article-title":"The rising tides of cancers among young adults","volume":"10","author":"Andr\u00e9","year":"2025","journal-title":"ESMO Open"},{"key":"2026100903524777600_djag191-B2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.breast.2021.12.006","article-title":"The impact of young age at diagnosis (age <40 years) on prognosis varies by breast cancer subtype: a U.S. SEER database analysis","volume":"61","author":"Kim","year":"2022","journal-title":"Breast"},{"key":"2026100903524777600_djag191-B3","doi-asserted-by":"publisher","author":"Statistics | Eurostat","year":"2025","DOI":"10.2908\/TPS00017"},{"key":"2026100903524777600_djag191-B4","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1056\/NEJMoa2212856","article-title":"Interrupting endocrine therapy to attempt pregnancy after breast cancer","volume":"388","author":"Partridge","year":"2023","journal-title":"N Engl J Med"},{"key":"2026100903524777600_djag191-B5","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1089\/jwh.2018.6962","article-title":"Pregnancy-associated cancer: a U.S. population-based study","volume":"28","author":"Cottreau","year":"2019","journal-title":"J Womens Health"},{"key":"2026100903524777600_djag191-B6","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1200\/OP-24-00867","article-title":"Pregnancy-associated breast cancer: key concepts for optimizing diagnosis and treatment","volume":"21","author":"Kesireddy","year":"2025","journal-title":"JCO Oncol Pract"},{"key":"2026100903524777600_djag191-B7","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.annonc.2023.08.001","article-title":"ESMO Expert Consensus Statements on the management of breast cancer during pregnancy (PrBC)","volume":"34","author":"Loibl","year":"2023","journal-title":"Ann Oncol"},{"key":"2026100903524777600_djag191-B8","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djag152","article-title":"Pregnancy history, recency of childbirth, and outcomes in young women with early- stage breast cancer","author":"Nader-Marta","year":"2026","journal-title":"J Natl Cancer Inst"},{"key":"2026100903524777600_djag191-B9","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s10549-016-3989-3","article-title":"The prognosis of women diagnosed with breast cancer before, during and after pregnancy: a meta-analysis","volume":"160","author":"Hartman","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"2026100903524777600_djag191-B10","doi-asserted-by":"publisher","first-page":"116230","DOI":"10.1016\/j.ejca.2026.116230","article-title":"Comprehensive review of pregnancy associated breast cancer: clinical features, molecular characteristics and novel therapies","volume":"235","author":"Spata","year":"2026","journal-title":"Eur J Cancer"},{"key":"2026100903524777600_djag191-B11","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1056\/NEJMoa1910549","article-title":"Pembrolizumab for early triple-negative breast cancer","volume":"382","author":"Schmid","year":"2020","journal-title":"N Engl J Med"},{"key":"2026100903524777600_djag191-B12","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.annonc.2025.10.019","article-title":"Neoadjuvant trastuzumab deruxtecan alone or followed by paclitaxel, trastuzumab, and pertuzumab for high-risk HER2-positive early breast cancer (DESTINY-Breast11): a randomised, open-label, multicentre, phase III trial","volume":"37","author":"Harbeck","year":"2026","journal-title":"Ann Oncol"},{"key":"2026100903524777600_djag191-B13","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1056\/NEJMoa2514661","article-title":"Trastuzumab deruxtecan in residual HER2-positive early breast cancer","volume":"394","author":"Loibl","year":"2026","journal-title":"N Engl J Med"},{"key":"2026100903524777600_djag191-B14","author":"US Food & Drug Administration","year":"2026"},{"key":"2026100903524777600_djag191-B15","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/s41571-026-01120-7","article-title":"Tailoring targeted therapies for younger women with ER-positive early-stage breast cancer","volume":"23","author":"Lobo-Martins","year":"2026","journal-title":"Nat Rev Clin Oncol"},{"key":"2026100903524777600_djag191-B16","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/s0002-9378(94)70290-x","article-title":"Survival of breast cancer patients after subsequent term pregnancy: \u201chealthy mother effect","volume":"170","author":"Sankila","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"2026100903524777600_djag191-B17","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1038\/s41590-025-02218-3","article-title":"Mammary intraepithelial lymphocytes and intestinal inputs shape T cell dynamics in lactogenesis","volume":"26","author":"Jaquish","year":"2025","journal-title":"Nat Immunol"},{"key":"2026100903524777600_djag191-B18","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1016\/j.cell.2025.01.028","article-title":"Mammary intraepithelial lymphocytes promote lactogenesis and offspring fitness","volume":"188","author":"Corral","year":"2025","journal-title":"Cell"},{"key":"2026100903524777600_djag191-B19","doi-asserted-by":"publisher","first-page":"110099","DOI":"10.1016\/j.celrep.2021.110099","article-title":"Parity-induced changes to mammary epithelial cells control NKT cell expansion and mammary oncogenesis","volume":"37","author":"Hanasoge Somasundara","year":"2021","journal-title":"Cell Rep"},{"key":"2026100903524777600_djag191-B20","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s43587-025-01058-y","article-title":"Induction of senescence during postpartum mammary gland involution supports tissue remodeling and promotes postpartum tumorigenesis","volume":"6","author":"Chiche","year":"2026","journal-title":"Nat Aging"},{"key":"2026100903524777600_djag191-B21","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41586-025-09713-5","article-title":"Parity and lactation induce T-cell-mediated breast cancer protection","volume":"649","author":"Virassamy","year":"2026","journal-title":"Nature"},{"key":"2026100903524777600_djag191-B22","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/annonc\/mdu450","article-title":"The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014","volume":"26","author":"Salgado","year":"2015","journal-title":"Ann Oncol"},{"key":"2026100903524777600_djag191-B23","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.cmet.2022.02.010","article-title":"The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer","volume":"34","author":"Wang","year":"2022","journal-title":"Cell Metab"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jnci\/advance-article-pdf\/doi\/10.1093\/jnci\/djag191\/70043748\/djag191.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/118\/10\/1788\/70043748\/djag191.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/118\/10\/1788\/70043748\/djag191.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T07:52:54Z","timestamp":1791532374000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/118\/10\/1788\/8741919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,25]]},"references-count":23,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,7,25]]},"published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djag191","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,7,25]]}}}